Skip to main content
TipRanks
Go Ultimate75% OFF

Kazia Therapeutics (KZIA) Ratios

341 Followers

Kazia Therapeutics Ratios

KZIA's free cash flow for Q4 2026 was AU$-12.51M. For the 2026 fiscal year, KZIA's free cash flow was increased by AU$0.00 and operating cash flow was AU$-12.51M. See a summary of the company’s cash flow.

Financial ratios
RatiosJun 26Jun 25Jun 24Jun 23Jun 22
Liquidity Ratios
Current Ratio2.330.350.241.421.40
Quick Ratio2.330.350.241.421.40
Cash Ratio1.920.310.060.691.09
Solvency Ratio-1.51-1.38-0.79-1.16-1.31
Operating Cash Flow Ratio-0.80-0.94-0.37-2.00-3.38
Short-Term Operating Cash Flow Coverage0.00-33.53-15.11-8.44-12.36
Net Current Asset ValueAU$ 35.13MAU$ -9.43MAU$ -25.46MAU$ -5.26MAU$ -8.16M
Leverage Ratios
Debt-to-Assets Ratio0.000.070.030.060.05
Debt-to-Equity Ratio0.00-0.05-0.060.150.10
Debt-to-Capital Ratio0.00-0.05-0.070.130.09
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio1.74-0.73-2.152.331.96
Debt Service Coverage Ratio0.00-29.13-41.52-12.25-12.56
Interest Coverage Ratio0.000.000.000.00-12129.42
Debt to Market Cap0.000.040.080.060.02
Interest Debt Per Share0.000.361.324.876.96
Net Debt to EBITDA1.600.300.040.150.23
Profitability Margins
Gross Profit Margin0.00%100.00%100.00%100.00%100.00%
EBIT Margin-31286.21%-33850.00%-1233.19%-4350725.59%-253840.00%
EBITDA Margin-31286.21%-31626.19%-1152.21%-4013885.95%-235150.00%
Operating Profit Margin-31286.21%-33850.00%-1233.19%-4346661.08%-253990.00%
Pretax Profit Margin-40717.28%-53447.62%-1171.97%-3736265.23%-253820.00%
Net Profit Margin-39973.27%-49290.48%-1160.23%-3687419.82%-250140.00%
Continuous Operations Profit Margin-39973.27%-49290.48%-1160.23%-3687419.82%-250140.00%
Net Income Per EBT98.17%92.22%99.00%98.69%98.55%
EBT Per EBIT130.14%157.90%95.04%85.96%99.93%
Return on Assets (ROA)-64.30%-341.56%-124.06%-72.87%-69.70%
Return on Equity (ROE)-111.93%249.39%267.33%-169.84%-136.88%
Return on Capital Employed (ROCE)-86.94%177.89%675.74%-117.57%-87.10%
Return on Invested Capital (ROIC)-85.35%172.61%787.50%-106.69%-80.74%
Return on Tangible Assets-65.43%-416.20%-432.95%-189.23%-149.34%
Earnings Yield-26.67%-198.39%-342.80%-63.79%-31.03%
Efficiency Ratios
Receivables Turnover0.320.4717.350.010.20
Payables Turnover0.000.000.000.000.00
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover0.000.000.000.000.00
Asset Turnover0.000.010.110.000.00
Working Capital Turnover Ratio0.01-0.00-0.280.000.00
Cash Conversion Cycle1136.26782.1421.0369054.051861.50
Days of Sales Outstanding1136.26782.1421.0369054.051861.50
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding0.000.000.000.000.00
Operating Cycle1136.26782.1421.0369054.051861.50
Cash Flow Ratios
Operating Cash Flow Per Share-2.84-12.12-19.98-41.12-85.89
Free Cash Flow Per Share-2.84-12.12-19.98-41.12-85.89
Dividend Paid and CapEx Coverage Ratio-7066099.000.000.000.000.00
Capital Expenditure Coverage Ratio-7066099.000.000.000.000.00
Operating Cash Flow Coverage Ratio0.00-33.53-15.11-8.44-12.36
Operating Cash Flow to Sales Ratio-208.82-316.14-4.15-27308.11-2276.20
Free Cash Flow Yield-13.93%-127.25%-122.65%-47.24%-28.24%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-3.77-0.50-0.29-1.57-3.22
Price-to-Sales (P/S) Ratio1498.58248.453.3857807.508060.35
Price-to-Book (P/B) Ratio4.20-1.26-0.782.664.41
Price-to-Free Cash Flow (P/FCF) Ratio-7.18-0.79-0.82-2.12-3.54
Price-to-Operating Cash Flow Ratio-7.18-0.79-0.82-2.12-3.54
Price-to-Earnings Growth (PEG) Ratio0.050.010.000.04-0.02
Enterprise Value Multiple-3.19-0.49-0.26-1.29-3.19
Enterprise Value101.19M6.49M6.79M28.64M75.08M
EV to EBITDA-3.19-0.49-0.26-1.29-3.19
EV to Sales996.77154.432.9451600.307508.35
EV to Free Cash Flow-4.77-0.49-0.71-1.89-3.30
EV to Operating Cash Flow-4.77-0.49-0.71-1.89-3.30
Tangible Book Value Per Share4.70-8.57-53.00-14.16-3.26
Shareholders’ Equity Per Share4.85-7.58-20.8932.6968.96
Tax and Other Ratios
Effective Tax Rate0.020.080.010.010.01
Revenue Per Share0.010.044.810.000.04
Net Income Per Share-5.43-18.90-55.83-55.52-94.39
Tax Burden0.980.920.990.990.99
Interest Burden1.301.580.950.861.00
Research & Development to Revenue105.99174.437.5328043.372016.90
SG&A to Revenue207.87207.625.8815464.89511.30
Stock-Based Compensation to Revenue0.0015.550.232088.29167.50
Income Quality0.520.640.360.740.91

Currency in AUD